Amplia Therapeutics Ltd. (AU:ATX) has released an update.
Amplia Therapeutics Ltd. is set to launch a significant accelerated offer, proposing the issue of over 74 million options and ordinary shares to boost its capital. The offer includes options with an exercise price of $0.1725, expiring in October 2027, and aims to attract both retail and institutional investors. Trading for these securities will resume on November 1, 2024, with the offer closing later in November.
For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
